158 related articles for article (PubMed ID: 23339543)
21. Anionic polymers for decreased toxicity and enhanced in vivo delivery of siRNA complexed with cationic liposomes.
Schlegel A; Largeau C; Bigey P; Bessodes M; Lebozec K; Scherman D; Escriou V
J Control Release; 2011 Jun; 152(3):393-401. PubMed ID: 21497175
[TBL] [Abstract][Full Text] [Related]
22. Rapid delivery of small interfering RNA by biosurfactant MEL-A-containing liposomes.
Inoh Y; Furuno T; Hirashima N; Kitamoto D; Nakanishi M
Biochem Biophys Res Commun; 2011 Oct; 414(3):635-40. PubMed ID: 22001930
[TBL] [Abstract][Full Text] [Related]
23. Design of a multicomponent peptide-woven nanocomplex for delivery of siRNA.
Jun E; Kim S; Kim JH; Cha K; So IS; Son HN; Lee BH; Kim K; Kwon IC; Kim SY; Kim IS
PLoS One; 2015; 10(2):e0118310. PubMed ID: 25705892
[TBL] [Abstract][Full Text] [Related]
24. DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery.
Zhang Y; Li H; Sun J; Gao J; Liu W; Li B; Guo Y; Chen J
Int J Pharm; 2010 May; 390(2):198-207. PubMed ID: 20116418
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy of RNA interference mediated by cationic liposomes].
Han W; Zhen Y; Zhang S; Zhao Y; Sun Y; Guo X; Wang E; Liu Z; Sun Y
Sheng Wu Gong Cheng Xue Bao; 2015 Aug; 31(8):1239-46. PubMed ID: 26762045
[TBL] [Abstract][Full Text] [Related]
26. A method for concentrating lipid peptide DNA and siRNA nanocomplexes that retains their structure and transfection efficiency.
Tagalakis AD; Castellaro S; Zhou H; Bienemann A; Munye MM; McCarthy D; White EA; Hart SL
Int J Nanomedicine; 2015; 10():2673-83. PubMed ID: 25878500
[TBL] [Abstract][Full Text] [Related]
27. HA-Modified R8-Based Bola-Amphiphile Nanocomplexes for Effective Improvement of siRNA Delivery Efficiency.
Jia N; Ma J; Gao Y; Hu H; Chen D; Zhao X; Yuan Y; Qiao M
ACS Biomater Sci Eng; 2020 Apr; 6(4):2084-2093. PubMed ID: 33455327
[TBL] [Abstract][Full Text] [Related]
28. Preparation of PEGylated cationic nanoliposome-siRNA complexes for cancer therapy.
Haghiralsadat F; Amoabediny G; Naderinezhad S; Forouzanfar T; Helder MN; Zandieh-Doulabi B
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):684-692. PubMed ID: 29475393
[TBL] [Abstract][Full Text] [Related]
29. RNA interference in vitro and in vivo using an arginine peptide/siRNA complex system.
Kim SW; Kim NY; Choi YB; Park SH; Yang JM; Shin S
J Control Release; 2010 May; 143(3):335-43. PubMed ID: 20079391
[TBL] [Abstract][Full Text] [Related]
30. Delivery of siRNA by MRI-visible nanovehicles to overcome drug resistance in MCF-7/ADR human breast cancer cells.
Lin G; Zhu W; Yang L; Wu J; Lin B; Xu Y; Cheng Z; Xia C; Gong Q; Song B; Ai H
Biomaterials; 2014 Nov; 35(35):9495-507. PubMed ID: 25155545
[TBL] [Abstract][Full Text] [Related]
31. Design and evaluation of endosomolytic biocompatible peptides as carriers for siRNA delivery.
Xu W; Pan R; Zhao D; Chu D; Wu Y; Wang R; Chen B; Ding Y; Sadatmousavi P; Yuan Y; Chen P
Mol Pharm; 2015 Jan; 12(1):56-65. PubMed ID: 25378277
[TBL] [Abstract][Full Text] [Related]
32. Gene delivery using ternary lipopolyplexes incorporating branched cationic peptides: the role of Peptide sequence and branching.
Welser K; Campbell F; Kudsiova L; Mohammadi A; Dawson N; Hart SL; Barlow DJ; Hailes HC; Lawrence MJ; Tabor AB
Mol Pharm; 2013 Jan; 10(1):127-41. PubMed ID: 23210981
[TBL] [Abstract][Full Text] [Related]
33. Small-interfering RNA (siRNA)-based functional micro- and nanostructures for efficient and selective gene silencing.
Lee SH; Chung BH; Park TG; Nam YS; Mok H
Acc Chem Res; 2012 Jul; 45(7):1014-25. PubMed ID: 22413937
[TBL] [Abstract][Full Text] [Related]
34. Novel fusion peptide-mediated siRNA delivery using self-assembled nanocomplex.
Ryu YC; Kim KA; Kim BC; Wang HD; Hwang BH
J Nanobiotechnology; 2021 Feb; 19(1):44. PubMed ID: 33579303
[TBL] [Abstract][Full Text] [Related]
35. Design and evaluation of a stearylated multicomponent peptide-siRNA nanocomplex for efficient cellular siRNA delivery.
Wan Y; Moyle PM; Gn PZ; Toth I
Nanomedicine (Lond); 2017 Feb; 12(4):281-293. PubMed ID: 28093948
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of two cationic delivery systems for siRNA.
Yadava P; Roura D; Hughes JA
Oligonucleotides; 2007; 17(2):213-22. PubMed ID: 17638525
[TBL] [Abstract][Full Text] [Related]
37. Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and their stability in simulated gastric conditions.
Ezzat K; Zaghloul EM; El Andaloussi S; Lehto T; El-Sayed R; Magdy T; Smith CI; Langel U
J Control Release; 2012 Aug; 162(1):1-8. PubMed ID: 22698942
[TBL] [Abstract][Full Text] [Related]
38. Lipopolyplexes comprising imidazole/imidazolium lipophosphoramidate, histidinylated polyethyleneimine and siRNA as efficient formulation for siRNA transfection.
Gonçalves C; Berchel M; Gosselin MP; Malard V; Cheradame H; Jaffrès PA; Guégan P; Pichon C; Midoux P
Int J Pharm; 2014 Jan; 460(1-2):264-72. PubMed ID: 24225347
[TBL] [Abstract][Full Text] [Related]
39. Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery.
Ping Y; Liu C; Zhang Z; Liu KL; Chen J; Li J
Biomaterials; 2011 Nov; 32(32):8328-41. PubMed ID: 21840593
[TBL] [Abstract][Full Text] [Related]
40. Storage stability of optimal liposome-polyethylenimine complexes (lipopolyplexes) for DNA or siRNA delivery.
Ewe A; Schaper A; Barnert S; Schubert R; Temme A; Bakowsky U; Aigner A
Acta Biomater; 2014 Jun; 10(6):2663-73. PubMed ID: 24590163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
